The single-day event was organized by the Marks Jewish Community House of Bensonhurst, @UJAfedNY, and @MobileHealthInc.
They had just days to contact some 800 mostly Russian-speaking survivors to coordinate time slots and transportation for those in need gothamist.com/news/more-300-…
“This is a humongous victory for us." - Alex Budnitsky, the executive director of the Marks Jewish Community House of Bensonhurst, which locals call the “J.”
His staff had spent weeks trying to find vaccine appointments through the normal channel. gothamist.com/news/more-300-…
Organizers said 318 received a shot on Thursday, including Zoltan and Mera Matyash.
During the opening ceremony, Mayor de Blasio said people who arrive without notice could be aided by “navigators” that could help book future appointments.
But on opening day yesterday, staff said they did not have access to the appointment system. 👀👀👀gothamist.com/news/citi-fiel…
South Africa halted use of the AstraZeneca-Oxford coronavirus vaccine on Sunday after evidence emerged that the vaccine did not protect trial participants from mild/moderate illness caused by the South African variant. nytimes.com/live/2021/02/0…
The disparity holds when you look at the overall number of doses administered (👇) and when you adjust for the population makeup for the city. gothamist.com/news/white-new… via @WNYC/@Gothamist
Contrary to what you would want to happen, the racial and ethnic disparities ***widen*** when you look at older adults over 65 (who are more likely to suffer severe consequences and thus have a greater need for the vaccine). gothamist.com/news/white-new…
While the J&J and Novavax vaccine trials show solid protection against the original strain, both struggled to contain the SA variant, suggesting the clock is ticking on their usefulness.
Early estimates suggested COVID vaccines need to be about 75% effective against infection to establish herd immunity, but Dr. Fauci recently said the mark could be closer to 90%.
If these two vaxs block viral spread at a similar rate as disease, then they may be too weak.
We've posed these questions to @JNJNews and @Novavax and are awaiting their responses.